Evidence map›Paper›PMID 41187128›Full record

ArticlePloS one2025

Long-term potentiation and neurotransmitters expression and segregation are altered in the Metabolic Syndrome-associated dysautonomia.

Diana Elinos, Fernanda Veladiz-Gracia, Constanza González-Sierra, Angel Rubio-Galicia, Fredy Cifuentes, Miguel A Morales

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Diana ElinosDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
Fernanda Veladiz-GraciaDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
Constanza González-SierraDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
Angel Rubio-GaliciaDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
Fredy CifuentesDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
Miguel A MoralesDepartamento de Biología Celular & Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID https://orcid.org/0000-0002-4058-9150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autonomic nervous system (ANS) dynamically regulates the internal environment to maintain homeostasis. The ANS exhibits some forms of synaptic plasticity, including long-term potentiation (LTP) and plastic changes in neurotransmitter distribution, both of which may contribute to autonomic function. Dysautonomia refers to an abnormality in the function of the ANS, with an imbalance between sympathetic and parasympathetic activity. Dysautonomia has been reported in conditions such as stress, hypertension, and metabolic syndrome (MS). MS is a cluster of risk factors for cardiovascular disease, diabetes, and premature death. In MS, the signs of dysautonomia include elevated plasma norepinephrine levels and increased arterial blood pressure. In this study, we characterized the effect of a high-sucrose diet (HSD) on synaptic plasticity in sympathetic ganglia of the rat by measuring LTP expression in the superior cervical ganglion (SCG) and analyzing the expression of acetylcholine (ACh) and GABA, as well as their balance of colocalization/segregation in ganglionic nerve terminals. The HSD consists of adding 30% sucrose to drinking water, which is an accepted model of MS. We observed an impairment in LTP expression, along with a decrease in ACh presence and a reduction in its segregation from GABA. These findings suggest the emergence of an inhibitory effect on synaptic transmission and plasticity within the SCG. We propose that dysautonomia associated with MS might involve changes in sympathetic activity, at least at the level of ganglionic cholinergic transmission. These results may help to improve our understanding of autonomic dysfunction in the context of this metabolic disorder.

Indexed as

Long-Term PotentiationMetabolic SyndromeNeurotransmitter AgentsPrimary DysautonomiasAcetylcholineAnimalsgamma-Aminobutyric AcidGanglia, SympatheticMaleNeuronal PlasticityRatsAcetylcholinegamma-Aminobutyric AcidNeurotransmitter Agents

Identifiers

PMID41187128
PMCPMC12585045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.